Eqwal Stomacare: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Eqwal Stomacare
Largest movements
- Receivables within one year +€152,657
up €152,657 (+7.9%), from €1.9m to €2.1m
of which Trade receivables: +€91,571
- Stocks and contracts +€94,913
up €94,913 (+94.1%), from €100,831 to €195,744
- Reserves +€234,500
up €234,500 (+24.3%), from €964,000 to €1.2m
- Tax, wage and social debts -€85,212
down €85,212 (-27.2%), from €313,738 to €228,526
of which Taxes: -€117,346
- Trade debts +€62,106
up €62,106 (+9.3%), from €667,156 to €729,262
- Gross operating margin -€117,583
down €117,583 (-7.8%), from €1.5m to €1.4m
- Write-downs -€79,997
down €79,997 (-45.6%), from €175,336 to €95,339
- Staff costs +€57,564
up €57,564 (+6.4%), from €898,325 to €955,889
- Taxes -€30,752
down €30,752 (-25.5%), from €120,414 to €89,661
- Financial income +€16,875
up €16,875 (+78.8%), from €21,403 to €38,278
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,489,002 | €2,678,788 | +€189,786 | +7.6% |
| Fixed assets | 21/28 | €102,255 | €53,015 | -€49,240 | -48.2% |
| Intangible fixed assets | 21 | €50,382 | €31,703 | -€18,679 | -37.1% |
| Tangible fixed assets | 22/27 | €44,598 | €19,662 | -€24,937 | -55.9% |
| Plant, machinery and equipment | 23 | €2,421 | €0 | -€2,421 | -100% |
| Furniture and vehicles | 24 | €42,177 | €19,662 | -€22,515 | -53.4% |
| Financial fixed assets | 28 | €7,275 | €1,650 | -€5,625 | -77.3% |
| Current assets | 29/58 | €2,386,747 | €2,625,773 | +€239,026 | +10.0% |
| Stocks and contracts in progress | 3 | €100,831 | €195,744 | +€94,913 | +94.1% |
| Stocks | 30/36 | €100,831 | €195,744 | +€94,913 | +94.1% |
| Amounts receivable within one year | 40/41 | €1,920,615 | €2,073,272 | +€152,657 | +7.9% |
| Trade receivables | 40 | €820,752 | €912,323 | +€91,571 | +11.2% |
| Other amounts receivable | 41 | €1,099,863 | €1,160,950 | +€61,086 | +5.6% |
| Cash at bank and in hand | 54/58 | €358,383 | €353,071 | -€5,312 | -1.5% |
| Deferred charges and accrued income | 490/1 | €6,917 | €3,685 | -€3,232 | -46.7% |
| Total equity and liabilities | 10/49 | €2,489,002 | €2,678,788 | +€189,786 | +7.6% |
| Equity | 10/15 | €984,896 | €1,218,787 | +€233,891 | +23.7% |
| Contributions | 10/11 | €20,000 | €20,000 | = | 0.0% |
| Reserves | 13 | €964,000 | €1,198,500 | +€234,500 | +24.3% |
| Distributable reserves | 133 | €964,000 | €1,198,500 | +€234,500 | +24.3% |
| Profit (loss) carried forward | 14 | €896 | €287 | -€609 | -67.9% |
| Amounts payable | 17/49 | €1,504,105 | €1,460,000 | -€44,105 | -2.9% |
| Amounts payable after more than one year | 17 | €2,212 | €0 | -€2,212 | -100% |
| Financial debts | 170/4 | €2,212 | €0 | -€2,212 | -100% |
| Amounts payable within one year | 42/48 | €1,501,893 | €1,460,000 | -€41,893 | -2.8% |
| Current portion of amounts payable after more than one year | 42 | €20,901 | €2,212 | -€18,689 | -89.4% |
| Trade debts | 44 | €667,156 | €729,262 | +€62,106 | +9.3% |
| Suppliers | 440/4 | €667,156 | €729,262 | +€62,106 | +9.3% |
| Taxes, remuneration and social security | 45 | €313,738 | €228,526 | -€85,212 | -27.2% |
| Taxes | 450/3 | €137,669 | €20,322 | -€117,346 | -85.2% |
| Remuneration and social security | 454/9 | €176,070 | €208,204 | +€32,134 | +18.3% |
| Other amounts payable | 47/48 | €500,098 | €500,000 | -€98 | 0.0% |
| Accrued charges and deferred income | 492/3 | €0 | - | = | |
| Remuneration, social security and pensions | 62 | €898,325 | €955,889 | +€57,564 | +6.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €46,342 | €41,194 | -€5,148 | -11.1% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €175,336 | €95,339 | -€79,997 | -45.6% |
| Other operating charges | 640/8 | €7,201 | €5,274 | -€1,927 | -26.8% |
| Gross operating margin | 9900 | €1,506,145 | €1,388,562 | -€117,583 | -7.8% |
| Operating profit (loss) | 9901 | €378,941 | €290,866 | -€88,074 | -23.2% |
| Financial income | 75/76B | €21,403 | €38,278 | +€16,875 | +78.8% |
| Recurring financial income | 75 | €21,403 | €38,278 | +€16,875 | +78.8% |
| Financial charges | 65/66B | €2,541 | €5,591 | +€3,050 | +120% |
| Recurring financial charges | 65 | €2,541 | €5,591 | +€3,050 | +120% |
| Profit (loss) for the period before taxes | 9903 | €397,802 | €323,552 | -€74,250 | -18.7% |
| Income taxes | 67/77 | €120,414 | €89,661 | -€30,752 | -25.5% |
| Profit (loss) for the period | 9904 | €277,388 | €233,891 | -€43,497 | -15.7% |
| Profit (loss) for the period to be appropriated | 9905 | €277,388 | €233,891 | -€43,497 | -15.7% |
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.